Wall Street Zen downgraded shares of Canopy Growth (NASDAQ:CGC – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday.
A number of other research analysts have also issued reports on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Canopy Growth in a report on Wednesday, January 21st. Alliance Global Partners reaffirmed a “neutral” rating on shares of Canopy Growth in a research report on Saturday. Finally, Benchmark upgraded Canopy Growth from a “sell” rating to a “hold” rating in a research note on Monday, November 10th. Three investment analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce”.
Read Our Latest Research Report on Canopy Growth
Canopy Growth Stock Up 1.9%
Canopy Growth (NASDAQ:CGC – Get Free Report) last announced its quarterly earnings data on Friday, November 7th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.10. The firm had revenue of $47.86 million during the quarter, compared to analysts’ expectations of $71.82 million. Canopy Growth had a negative net margin of 113.21% and a negative return on equity of 61.97%. Analysts predict that Canopy Growth will post -2.81 EPS for the current year.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the business. Tidal Investments LLC lifted its stake in Canopy Growth by 31.5% during the second quarter. Tidal Investments LLC now owns 5,033,793 shares of the company’s stock worth $6,141,000 after purchasing an additional 1,204,530 shares during the last quarter. Millennium Management LLC increased its stake in Canopy Growth by 196.9% in the third quarter. Millennium Management LLC now owns 3,137,696 shares of the company’s stock valued at $4,579,000 after purchasing an additional 2,080,994 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in Canopy Growth by 19,571.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,022,197 shares of the company’s stock worth $2,305,000 after purchasing an additional 2,011,917 shares in the last quarter. Two Sigma Investments LP purchased a new stake in shares of Canopy Growth during the 3rd quarter worth approximately $1,767,000. Finally, Jones Financial Companies Lllp boosted its holdings in shares of Canopy Growth by 10,308.3% in the 1st quarter. Jones Financial Companies Lllp now owns 969,533 shares of the company’s stock valued at $882,000 after buying an additional 960,218 shares in the last quarter. Hedge funds and other institutional investors own 3.33% of the company’s stock.
Canopy Growth News Roundup
Here are the key news stories impacting Canopy Growth this week:
- Positive Sentiment: Revenue beat and narrower loss — Canopy reported Q3 revenue above Street estimates and reduced its per?share loss while highlighting ongoing cost-saving measures, which supports near-term cash preservation and investor confidence. Read More.
- Positive Sentiment: Management signals positive adjusted EBITDA for fiscal 2027 and an MTL acquisition with greater European focus — guidance toward adjusted EBITDA positivity and strategic M&A give investors a multi-quarter runway to improved profitability. Read More.
- Neutral Sentiment: Earnings call transcript and highlights available — Management discussed growth priorities and cost actions on the Q3 call; read the transcript and highlights for detail on cadence of margin recovery and European execution risk. Read More. Read More.
- Neutral Sentiment: Short-interest report appears unreliable — a posted large increase shows zero shares/NaN values and days-to-cover of 0.0, so short-interest data is not meaningful right now and shouldn’t be driving sentiment. (Internal data)
- Negative Sentiment: EPS missed consensus — CGC reported a loss per share larger than estimates (reported ($0.10) vs. consensus about ($0.03)), which pressures near-term valuation and keeps skepticism about earnings quality. Read More.
- Negative Sentiment: Analyst downgrades and negative coverage — Wall Street Zen cut CGC to “Sell” and outlets like The Motley Fool have run critical pieces calling the investment poor due to prior dilution, aggressive expansion and sector headwinds; these narratives can amplify selling pressure. Read More. Read More.
Canopy Growth Company Profile
Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.
The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.
Featured Articles
- Five stocks we like better than Canopy Growth
- Trade this between 9:30 and 10:45 am EST
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- The buying spree that no one is talking about
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
